Metformin Research Paper

208 Words1 Page
According to www.drugbank.ca/drugs/db00331 metformin is a biguanide antihypergylcemic used to treat type 2 diabetes by the improvement of glycemic control by hepatic glucose production, glucose absorption being decreased, while increasing insulin-mediated glucose uptake. Induction of weight loss may be by incurred by metformin, as this is the drug of choice for obese patients. Metformin used alone does not cause hypoglycaemia; but may potentiate hypoglycemic effects of insulin. Fasting plasma glucose, postprandial blood glucose along with glycosolated haemoglobin (HbA1c) levels are decreased with the use of metformin, which are reflective of the last 8-10 weeks of glucose control. Insulin is a hormone which helps with the control of blood
Show More
Related

  • Epalrestat Case Study

    2170 Words  | 9 Pages

    Statistical approaches in the pharmaceutical formulations have the advantages. Central composite design (CCD) was used for this purpose. In the study the computerized software Design expert 9 was used for the implementation of CCD. The target of this research is to develop the controlled release tablets of epalrestat, five formulations were chosen by using central composite design (CCD) in response surface methodology (RSM). The results were not according to the plan for which the experiment was planned

    Read More

More about Metformin Research Paper

Open Document